Salmeron Kathleen, Aihara Takuma, Redondo-Castro Elena, Pinteaux Emmanuel, Bix Gregory
Sanders Brown Center on Aging, University of Kentucky, Lexington, Kentucky, USA.
Faculty of Life Sciences, University of Manchester, Manchester, UK.
J Neurochem. 2016 Feb;136(3):573-80. doi: 10.1111/jnc.13422. Epub 2015 Nov 27.
Inflammation is a major contributor to neuronal injury and is associated with poor outcome after acute brain injury such as stroke. The pro-inflammatory cytokine interleukin (IL)-1 is a critical regulator of cerebrovascular inflammation after ischemic injury, mainly through action of both of its isoforms, IL-1α and IL-1β, at the brain endothelium. In contrast, the differential action of these ligands on endothelial activation and post-stroke angiogenesis is largely unknown. Here, we demonstrate that IL-1α is chronically elevated in the brain after experimental stroke suggesting that it is present during post-stroke angiogenic periods. Furthermore, we demonstrate that IL-1α is a potent mediator of endothelial activation and inducer of angiogenic markers in endothelial cells in vitro. Using brain endothelial cell lines, we found that IL-1α was significantly more potent than IL-1β at inducing endothelial cell activation, as measured by expression of the pro-angiogenic chemokine CXCL-1. IL-1α also induced strong expression of the angiogenic mediator IL-6 in a concentration-dependent manner. Furthermore, IL-1α induced significant proliferation and migration of endothelial cells, and promoted formation of tube-like structures that are established key hallmarks of angiogenesis in vitro. Finally, all of those responses were blocked by the IL-1 receptor antagonist (IL-1RA). In conclusion, our data highlights a potential new role for IL-1 in brain repair mechanisms and identifies IL-1α as a potential new therapy to promote post-stroke angiogenesis. Inflammation is a major contributor to neuronal injury and is associated with poor outcome after neurotrauma. We demonstrate that cytokine IL-1α is chronically elevated in the brain after experimental stroke suggesting that it is present chronically post-stroke. We demonstrate that IL-1α is a potent mediator of endothelial activation and inducer of angiogenic markers in endothelial cells. Our data highlights a new role for IL-1 in brain repair mechanisms and identifies IL-1α as a potential therapy to promote post-stroke angiogenesis.
炎症是神经元损伤的主要促成因素,与急性脑损伤(如中风)后的不良预后相关。促炎细胞因子白细胞介素(IL)-1是缺血性损伤后脑血管炎症的关键调节因子,主要通过其两种同工型IL-1α和IL-1β作用于脑内皮细胞。相比之下,这些配体对内皮细胞活化和中风后血管生成的不同作用在很大程度上尚不清楚。在此,我们证明实验性中风后大脑中IL-1α长期升高,表明其在中风后血管生成期存在。此外,我们证明IL-1α是体外内皮细胞活化的有效介质和血管生成标志物的诱导剂。使用脑内皮细胞系,我们发现,通过促血管生成趋化因子CXCL-1的表达来衡量,IL-1α在诱导内皮细胞活化方面比IL-1β显著更有效。IL-1α还以浓度依赖的方式诱导血管生成介质IL-6的强烈表达。此外,IL-1α诱导内皮细胞显著增殖和迁移,并促进体外形成管状结构,这是血管生成的关键标志。最后,所有这些反应都被IL-1受体拮抗剂(IL-1RA)阻断。总之,我们的数据突出了IL-1在脑修复机制中的潜在新作用,并确定IL-1α是促进中风后血管生成的潜在新疗法。炎症是神经元损伤的主要促成因素,与神经创伤后的不良预后相关。我们证明实验性中风后大脑中细胞因子IL-1α长期升高,表明其在中风后长期存在。我们证明IL-1α是内皮细胞活化的有效介质和血管生成标志物的诱导剂。我们的数据突出了IL-1在脑修复机制中的新作用,并确定IL-1α是促进中风后血管生成的潜在疗法。